GlassScriptPhysician profile
Anesh P Rugnath
NPI 1821367053
$9,608.70
in general payments reported to CMS, 2019-2025
18 companies · $1,565 in 2025
The $1,565 reported for 2025 was more than what 77% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $869 · 2020: $881 · 2021: $1,557 · 2022: $2,046 · 2023: $1,438 · 2024: $1,253 · 2025: $1,565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,256.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,584.03 | 2019-2025 | Proclaim, Eterna, Prodigy |
| Boston Scientific Corporation | $1,924.61 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16, General - Therapies |
| Medtronic, INC. | $1,346.82 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Kyphon Express II Kyphopak Tray |
| Nevro Corp. | $672.55 | 2019-2024 | Senza |
| Nalu Medical, INC. | $229.13 | 2023-2025 | Nalu Neurostimulation System |
| Avanos Medical | $220.01 | 2019-2025 | Coolief Cooled Radiofrequency, Coolief* Cooled Radiofrequency |
| Averitas Pharma INC. | $137.56 | 2023-2025 | Qutenza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $136.37 | 2023 | Relistor |
| Stryker Corporation | $84.99 | 2019 | |
| Medtronic USA, INC. | $84.92 | 2019-2020 | |
| Si-Bone, INC. | $47.28 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $37.80 | 2024 | Exparel |
| Biotronik Nro, INC. | $29.95 | 2025 | Prospera |
| 3m Company | $20.56 | 2019 | |
| Grt US Holding, INC. | $15.28 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $13.63 | 2025 | Reactiv8 |
| Pfizer INC. | $12.04 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anesh Rugnath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.